348 related articles for article (PubMed ID: 30905549)
1. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
3. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
5. Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
Cassidy RJ; Liu Y; Patel K; Zhong J; Steuer CE; Kooby DA; Russell MC; Gillespie TW; Landry JC
Cancer; 2017 Mar; 123(5):783-793. PubMed ID: 27780316
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiotherapy followed by metastasectomy converts to survival benefit in stage IV rectum cancer.
Lin JK; Lee LK; Chen WS; Lin TC; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Yen CC; Liu JH; Tzeng CH; Teng HW
J Gastrointest Surg; 2012 Oct; 16(10):1888-96. PubMed ID: 22833439
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.
Lund JL; Sturmer T; Sanoff HK
J Geriatr Oncol; 2016 May; 7(3):176-86. PubMed ID: 26926829
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.
Wells SM; Boothe D; Ager BJ; Tao R; Gilcrease GW; Lloyd S
Clin Colorectal Cancer; 2020 Jun; 19(2):91-99.e1. PubMed ID: 32173281
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
13. Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer.
Ng SY; Colborn KL; Cambridge L; Cercek A; Reidy-Lagunes DL; Segal N; Stadler Z; Saltz LB; Paty PB; Guillem J; Weiser MR; Nash G; Garcia-Aguilar J; Goodman KA
Clin Colorectal Cancer; 2019 Sep; 18(3):167-174. PubMed ID: 31104990
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
15. Defining the Role of Minimally Invasive Proctectomy for Locally Advanced Rectal Adenocarcinoma.
Sujatha-Bhaskar S; Jafari MD; Gahagan JV; Inaba CS; Koh CY; Mills SD; Carmichael JC; Stamos MJ; Pigazzi A
Ann Surg; 2017 Oct; 266(4):574-581. PubMed ID: 28650357
[TBL] [Abstract][Full Text] [Related]
16. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract][Full Text] [Related]
17. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
Lee WC; Yusof MM; Lau FN; Phua VC
Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
19. Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
Feng YR; Jin J; Ren H; Wang X; Wang SL; Wang WH; Song YW; Liu YP; Tang Y; Li N; Liu XF; Fang H; Yu ZH; Li YX
BMC Cancer; 2017 Mar; 17(1):182. PubMed ID: 28279170
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]